|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-9-5
|
|
pubmed:abstractText |
Imaging with radiolabeled somatostatin (SST) analogs has recently been established for the localization of various human SST receptor (hsstr)-positive tumors, including neuroendocrine tumors, lymphomas, and non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1309-15
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11535718-Case-Control Studies,
pubmed-meshheading:11535718-Diagnosis, Differential,
pubmed-meshheading:11535718-Heterocyclic Compounds, 1-Ring,
pubmed-meshheading:11535718-Indium Radioisotopes,
pubmed-meshheading:11535718-Lung Neoplasms,
pubmed-meshheading:11535718-Neoplasm Metastasis,
pubmed-meshheading:11535718-Peptides, Cyclic,
pubmed-meshheading:11535718-Radiometry,
pubmed-meshheading:11535718-Radiopharmaceuticals,
pubmed-meshheading:11535718-Somatostatin,
pubmed-meshheading:11535718-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, and Ludwig Boltzmann Institute of Nuclear Medicine, University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
